WHO in the context of "Gender"

⭐ In the context of Gender, the differentiation between an individual's biological attributes and their social/psychological identity became a significant focus in academic disciplines starting in…

Ad spacer

⭐ Core Definition: WHO

The World Health Organization (WHO) is a specialized agency of the United Nations which coordinates responses to international public health issues and emergencies. It is headquartered in Geneva, Switzerland, and has six regional offices and 150 field offices worldwide. Only sovereign states are eligible to join, and it is the largest intergovernmental health organization at the international level.

The WHO's purpose is to achieve the highest possible level of health for all the world's people, defining health as "a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity." The main functions of the World Health Organization include promoting the control of epidemic and endemic diseases; providing and improving the teaching and training in public health, the medical treatment of disease, and related matters; and promoting the establishment of international standards for biological products.

↓ Menu

>>>PUT SHARE BUTTONS HERE<<<

👉 WHO in the context of Gender

Gender is the range of social, psychological, cultural, and behavioral aspects of being a man (or boy), woman (or girl), or third gender. Although gender often corresponds to sex, a transgender person may identify with a gender other than their sex assigned at birth. Most cultures use a gender binary, in which gender is divided into two categories, and people are considered part of one or the other; those who are outside these groups may fall under the umbrella term non-binary. Some societies have third genders (and fourth genders, etc.) such as the hijras of South Asia and two-spirit persons native to North America. Most scholars agree that gender is a central characteristic for social organization; this may include social constructs (i.e. gender roles) as well as gender expression.

The word has been used as a synonym for sex, and the balance between these usages has shifted over time. In the mid-20th century, a terminological distinction in modern English (known as the sex and gender distinction) between biological sex and gender began to develop in the academic areas of psychology, sociology, sexology, and feminism. Before the mid-20th century, it was uncommon to use the word gender to refer to anything but grammatical categories. In the West, in the 1970s, feminist theory embraced the concept of a distinction between biological sex and the social construct of gender. The distinction between gender and sex is made by most contemporary social scientists in Western countries, behavioral scientists and biologists, many legal systems and government bodies, and intergovernmental agencies such as the WHO. The experiences of intersex people also testify to the complexity of sex and gender; female, male, and other gender identities are experienced across the many divergences of sexual difference.

↓ Explore More Topics
In this Dossier

WHO in the context of Sex and gender distinction

While in ordinary speech, the terms sex and gender are often used interchangeably, in contemporary academic literature, the terms often have distinct meanings, especially when referring to people. Sex generally refers to an organism's assigned biological sex, while gender usually refers to either social roles typically associated with the sex of a person (gender role) or personal identification of one's own gender based on their own personal sense of it (gender identity).

Most contemporary social scientists, behavioral scientists and biologists, many legal systems and government bodies and intergovernmental agencies such as the WHO make a distinction between gender and sex. In most individuals, the various biological determinants of sex are congruent, and sex is consistent with the individual's gender identity, but in rare circumstances, an individual's assigned sex and gender do not align, and the person may be transgender.

↑ Return to Menu

WHO in the context of Dichlorodiphenyltrichloroethane

Dichlorodiphenyltrichloroethane (DDT) is a colorless, tasteless, and almost odorless crystalline chemical compound, an organochloride. Originally developed as an insecticide, it became infamous for its environmental impacts. DDT was first synthesized in 1874 by the Austrian chemist Othmar Zeidler. DDT's insecticidal action was discovered by the Swiss chemist Paul Hermann Müller in 1939. DDT was used in the second half of World War II to limit the spread of the insect-borne diseases malaria and typhus among civilians and troops. Müller was awarded the Nobel Prize in Physiology or Medicine in 1948 "for his discovery of the high efficiency of DDT as a contact poison against several arthropods". The WHO's anti-malaria campaign of the 1950s and 1960s relied heavily on DDT and the results were promising, though there was a resurgence in developing countries afterwards.

↑ Return to Menu

WHO in the context of Birth asphyxia

Perinatal asphyxia (also known as neonatal asphyxia or birth asphyxia) is the medical condition resulting from deprivation of oxygen to a newborn infant that lasts long enough during the birth process to cause physical harm, usually to the brain. It remains a serious condition which causes significant mortality and morbidity. It is also the inability to establish and sustain adequate or spontaneous respiration upon delivery of the newborn, an emergency condition that requires adequate and quick resuscitation measures. Perinatal asphyxia is also an oxygen deficit from the 28th week of gestation to the first seven days following delivery. It is also an insult to the fetus or newborn due to lack of oxygen or lack of perfusion to various organs and may be associated with a lack of ventilation. In accordance with WHO, perinatal asphyxia is characterised by: profound metabolic acidosis, with a pH less than 7.20 on umbilical cord arterial blood sample, persistence of an Apgar score of 3 at the 5th minute, clinical neurologic sequelae in the immediate neonatal period, or evidence of multiorgan system dysfunction in the immediate neonatal period. Hypoxic damage can occur to most of the infant's organs (heart, lungs, liver, gut, kidneys), but brain damage is of most concern and perhaps the least likely to quickly or completely heal. In more pronounced cases, an infant will survive, but with damage to the brain manifested as either mental, such as developmental delay or intellectual disability, or physical, such as spasticity.

It results most commonly from antepartum causes like a drop in maternal blood pressure or some other substantial interference with blood flow to the infant's brain during delivery. This can occur due to inadequate circulation or perfusion, impaired respiratory effort, or inadequate ventilation. Perinatal asphyxia happens in 2 to 10 per 1000 newborns that are born at term, and more for those that are born prematurely. WHO estimates that 4 million neonatal deaths occur yearly due to birth asphyxia, representing 38% of deaths of children under 5 years of age.

↑ Return to Menu

WHO in the context of International Society of Doctors for the Environment

The International Society of Doctors for the Environment (ISDE) is an NGO, founded at Cortona on 25 November 1990, by doctors of various nationalities, in order to gather all doctors interested in medical problems related to ecological problems, spread awareness of the connection between environmental pollution and human health, start and support initiatives from local to global levels, and to reduce or eliminate sources of pollution and environmental pollution. ISDE has consultative status with the WHO and the United Nations Economic and Social Council.

↑ Return to Menu

WHO in the context of Barkat Pharmaceutical Group

Barkat Pharmaceutical Group (Persian: گروه دارویی برکت, Gruh-e Darvii-ye Berekât) is an Iranian Pharmaceutical public company, which was founded in 2010, named Tadbir innovation pharmaceutical company. The company provides services through cooperation between science-based institutions and scientists based on medicine around the world. It supplies 14 percent of all the country's essential drugs through its 25 subsidiaries. The company produces 700 kinds of products in the pharmaceutical sector and offers it internally.

The Barkat Pharmaceutical Group has established as the first specialized drug and pharmaceutical research center in Iran, also it has been developed by constructing advanced pharmaceutical factories, called Barkat Pharmaceutical Town. The Barkat group complies with all common pharmaceutical standards such as the FDA, WHO, EMEA. "Cell therapy", production of "peptide medications", "research, development and processing of medicinal plants," the creation of the "Museum of Iranian-Islamic Medicine" as well as "Solids and Semi-Solids" projects are the main activities of the Group.

↑ Return to Menu